-
2
-
-
80052008891
-
Baruch blumberg (1925-2011)
-
Alter H. Baruch blumberg (1925-2011). Nature 2011;473(7346):155
-
(2011)
Nature
, vol.473
, Issue.7346
, pp. 155
-
-
Alter, H.1
-
3
-
-
67651208017
-
How do good health technologies get topoor people in poor countires
-
Access Cambridge, MA, USA
-
Frost LJ, Reich MR. Access. How do good health technologies get topoor people in poor countires?. Harvard Center for Population and Development Studies, Cambridge, MA, USA; 2008. p. 68-90
-
(2008)
Harvard Center for Population and Development Studies
, pp. 68-90
-
-
Frost, L.J.1
Reich, M.R.2
-
4
-
-
55249103335
-
The global impact of vaccination against hepatitis B: A historical overview
-
Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 2008;26(49):6266-73
-
(2008)
Vaccine
, vol.26
, Issue.49
, pp. 6266-6273
-
-
Zanetti, A.R.1
Van Damme, P.2
Shouval, D.3
-
5
-
-
84924712363
-
-
Media centre, hepatitis B. 2014. Available from Last accessed on 19 November
-
WHO. Media centre, hepatitis B. 2014. Available from: www.who.int/mediacentre/factsheets/fs204/en/[Last accessed on 19 November 2014]
-
(2014)
-
-
WHO1
-
6
-
-
84865376141
-
Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update
-
Liaw Y-F, Kao J-H, Piratvisuth T, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hpatol Int 2012;6:531-61
-
(2012)
Hpatol Int
, vol.6
, pp. 531-561
-
-
Liaw, Y.-F.1
Kao, J.-H.2
Piratvisuth, T.3
-
7
-
-
70349731726
-
A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J
-
Tatematsu K, Tanaka Y, Kurbanov F, et a l. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol 2009;83(20):10538-47
-
(2009)
J Virol
, vol.83
, Issue.20
, pp. 10538-10547
-
-
Tatematsu, K.1
Tanaka, Y.2
Kurbanov, F.3
-
8
-
-
59749096640
-
Hepatitis B virus infection
-
Liaw YF,Chu CM., Hepatitis B virus infection, Lancet, 2009, 373, 9663, 582-92.
-
(2009)
Lancet
, vol.373
, Issue.9663
, pp. 582-592
-
-
Liaw, Y.F.1
Chu, C.M.2
-
9
-
-
38049044476
-
Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
-
Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008;48(2): 335-52
-
(2008)
J Hepatol
, vol.48
, Issue.2
, pp. 335-352
-
-
Fattovich, G.1
Bortolotti, F.2
Donato, F.3
-
10
-
-
79958796264
-
Natural history of chronic hepatitis B in Euro-Mediterranean and African countries
-
Hadziyannis SJ. Natural history of chronic hepatitis B in Euro-Mediterranean and African countries. J Hepatol 2011;55(1): 183-91
-
(2011)
J Hepatol
, vol.55
, Issue.1
, pp. 183-191
-
-
Hadziyannis, S.J.1
-
11
-
-
84862664371
-
EASL clinical practice guidelines: Management of chronic hepatitis B virus infection
-
European association for the study of the liver
-
European association for the study of the liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012;57(1):167-85
-
(2012)
J Hepatol
, vol.57
, Issue.1
, pp. 167-185
-
-
-
12
-
-
35648994427
-
Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A,B,C,D, and F
-
Livingsto n SE, Simonetti JP, Bulkow LR, et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology 2007;133(5):1452-7
-
(2007)
Gastroenterology
, vol.133
, Issue.5
, pp. 1452-1457
-
-
Livingston, S.E.1
Simonetti, J.P.2
Bulkow, L.R.3
-
13
-
-
84924712361
-
-
Global alert and response, hepatitis. B. Available from
-
WHO. Global alert and response, hepatitis. B. Available from: www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index5.html [Last accessed on 19 November 2014]
-
(2014)
Last Accessed on 19 November
-
-
WHO1
-
14
-
-
84924712359
-
-
Immunization vaccines and biologicals hepatitis B. Available from Last accessed on 19 November
-
WHO. Immunization, vaccines and biologicals, hepatitis B. Available from: http://whqlibdoc.who.int/hq/2001/WHÓV&B-01.28.pdf?ua=1 [Last accessed on 19 November 2014]
-
(2014)
-
-
WHO1
-
15
-
-
43049156557
-
A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Cote d'Ivoire
-
Ekra D, Herbinger KH, Ko nate S, et al. A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Cote d'Ivoire. Vaccine 2008;26(22):2753-61
-
(2008)
Vaccine
, vol.26
, Issue.22
, pp. 2753-2761
-
-
Ekra, D.1
Herbinger, K.H.2
Konate, S.3
-
16
-
-
84891827981
-
Hepatitis B virus exposure during childhood in cameroon, central african republic and senegal after the integration of HBV vaccine in the expanded program on immunization
-
Rey-Cuille MA, Njouom R, Bekondi C, et al. Hepatitis B virus exposure during childhood in cameroon, central african republic and senegal after the integration of HBV vaccine in the expanded program on immunization. Pediatr Infect Dis J 2013; 32(10):1110-15
-
(2013)
Pediatr Infect Dis J
, vol.32
, Issue.10
, pp. 1110-1115
-
-
Rey-Cuille, M.A.1
Njouom, R.2
Bekondi, C.3
-
17
-
-
84870510920
-
Cost-effectiveness analysis of an additional birth dose of Hepatitis B vaccine to prevent perinatal transmission in a medical sett ing in Mozambique
-
Klingler C, Thoumi AI, Mrithinjayam VS. Cost-effectiveness analysis of an additional birth dose of Hepatitis B vaccine to prevent perinatal transmission in a medical sett ing in Mozambique. Vaccine 2012;31(1):252-9
-
(2012)
Vaccine
, vol.31
, Issue.1
, pp. 252-259
-
-
Klingler, C.1
Thoumi, A.I.2
Mrithinjayam, V.S.3
-
18
-
-
84900839982
-
Prevention of materno-foetal transmission of hepatitis B in sub-Saharan Africa: The evidence, current practice and future ch allenges
-
Howell J, Lemoine M, Thursz M. Prevention of materno-foetal transmission of hepatitis B in sub-Saharan Africa: the evidence, current practice and future ch allenges. J Viral Hepat 2014;21(6):381-96
-
(2014)
J Viral Hepat
, vol.21
, Issue.6
, pp. 381-396
-
-
Howell, J.1
Lemoine, M.2
Thursz, M.3
-
19
-
-
77954550440
-
Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dha ka, Bangladesh
-
Ashraf H, Alam NH, Rothermundt C, et al. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dha ka, Bangladesh. BMC Infect Dis 2010;10:208
-
(2010)
BMC Infect Dis
, vol.10
, pp. 208
-
-
Ashraf, H.1
Alam, N.H.2
Rothermundt, C.3
-
20
-
-
84892393046
-
Reprint of: Epidemiological serosurvey of Hepatitis B in China-declining HBV prevalence due to Hepatitis B vaccination
-
Liang X, Bi S, Yang W, et al. Reprint of: epidemiological serosurvey of Hepatitis B in China-declining HBV prevalence due to Hepatitis B vaccinatio n. Vaccine 2013; 31(Suppl 9):J21-8
-
(2013)
Vaccine
, vol.31
, pp. J21-J28
-
-
Liang, X.1
Bi, S.2
Yang, W.3
-
21
-
-
77954612056
-
Serologic and molecular characteristics of hepatitis B virus among school children in East Java, Indonesia
-
Utsumi T, Yano Y, Lusida MI, et al. Serologic and molecular characteristics of hepatitis B virus among school children in East Java, Indonesia. Am J Trop M ed Hyg 2010;83(1):189-93
-
(2010)
Am J Trop Med Hyg
, vol.83
, Issue.1
, pp. 189-193
-
-
Utsumi, T.1
Yano, Y.2
Lusida, M.I.3
-
22
-
-
0141838644
-
Prevention of perinatal hepatitis B virus transmission by combined passive-active immunoprophylaxis in Iwate, Japan 1981-1992 and epidemiological evidence for its efficacy
-
Koyama T, Matsuda I, Sato S, Yoshizawa H. Prevention of perinatal hepatitis B virus transmission by combined passive-active immunoprophylaxis in Iwate, Japan (1981 - 1992) and epidemiological evidence for its efficacy. Hepatol Res 2003;26(4):287-92
-
(2003)
Hepatol Res
, vol.26
, Issue.4
, pp. 287-292
-
-
Koyama, T.1
Matsuda, I.2
Sato, S.3
Yoshizawa, H.4
-
23
-
-
84892467242
-
Viral hepatitis and liver cancer in Korea: An epidemiological perspective
-
Yeo Y, Gwack J, Kang S, et al. Viral hepatitis and liver cancer in Korea: an epidemiological perspective. Asian Pac J Cancer Prev 2013;14(11):6227-31
-
(2013)
Asian Pac J Cancer Prev
, vol.14
, Issue.11
, pp. 6227-6231
-
-
Yeo, Y.1
Gwack, J.2
Kang, S.3
-
24
-
-
84896509632
-
Chronic hepatitis b prevalence among children and mothers: Results from a nationwide population-based s urvey in lao people's democratic republic
-
Xeuatvongsa A, Komada K, Kitamura T, et al. Chronic hepatitis B prevalence among children and mothers: results from a nationwide, population-based s urvey in Lao People's Democratic Republic. PLoS One 2014;9(2):e88829
-
(2014)
PLoS One
, vol.9
, Issue.2
, pp. e88829
-
-
Xeuatvongsa, A.1
Komada, K.2
Kitamura, T.3
-
25
-
-
33847647203
-
Seroepidemiology of hepatitis B virus infection among children in Mongolia: Results of a nationwide survey
-
Davaalkham D, Ojima T, Nymadawa P, et al. Seroepidemiology of hepatitis B virus infection among children in Mongolia: results of a nationwide survey. Pediatr Int 2007;49(3):368-74
-
(2007)
Pediatr Int
, vol.49
, Issue.3
, pp. 368-374
-
-
Davaalkham, D.1
Ojima, T.2
Nymadawa, P.3
-
26
-
-
84903817184
-
Prevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in Nepal
-
Upreti SR, Gurung S, Patel M, et al. Prevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B v accination program among children in Nepal. Vaccine 2014;32(34): 4304-9
-
(2014)
Vaccine
, vol.32
, Issue.34
, pp. 4304-4309
-
-
Upreti, S.R.1
Gurung, S.2
Patel, M.3
-
27
-
-
84886083958
-
Progress toward elimination of hepatitis B virus transmission in Oman: Impa ct of hepatitis B vaccination
-
Al Awaidy ST, Bawikar SP, Al Busaidy SS, et al. Progress toward elimination of hepatitis B virus transmission in Oman: impa ct of hepatitis B vaccination. Am J Trop Med Hyg 2013;89(4):811-15
-
(2013)
Am J Trop Med Hyg
, vol.89
, Issue.4
, pp. 811-815
-
-
Al Awaidy, S.T.1
Bawikar, S.P.2
Al Busaidy, S.S.3
-
28
-
-
33747161320
-
Hepatitis B and C: Prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan
-
Jafri W, Jafri N, Yakoob J, et al. Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan. BMC Infect Dis 2006;6:101
-
(2006)
BMC Infect Dis
, vol.6
, pp. 101
-
-
Jafri, W.1
Jafri, N.2
Yakoob, J.3
-
29
-
-
74049120914
-
Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the marshall islands and the federated States of micronesia
-
Bi alek SR, Helgenberger L, Fischer GE, et al. Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the marshall islands and the federated States of micronesia. Pediatr Infect Dis J 2010;29(1): 18-22
-
(2010)
Pediatr Infect Dis J
, vol.29
, Issue.1
, pp. 18-22
-
-
Bialek, S.R.1
Helgenberger, L.2
Fischer, G.E.3
-
30
-
-
84873943142
-
Seroprevalence of hepatitis B virus infection among children and adolescents in Singapore, 2008-2010
-
Ang LW,Tey SH,Cutter J,et al., Seroprevalence of hepatitis B virus infection among children and adolescents in Singapore, 2008-2010, J Med Virol, 2013, 85, 4, 583-8.
-
(2013)
J Med Virol
, vol.85
, Issue.4
, pp. 583-588
-
-
Ang, L.W.1
Tey, S.H.2
Cutter, J.3
-
31
-
-
0141892052
-
The decline of hepatitis B viral infection in south-western saudi arabia
-
Ayoola AE, Tobaigy MS, Gadour MO, et al. The decline of hepatitis B viral infection in south-western saudi arabia. Saudi Med J 2003;24(9):991-5
-
(2003)
Saudi Med J
, vol.24
, Issue.9
, pp. 991-995
-
-
Ayoola, A.E.1
Tobaigy, M.S.2
Gadour, M.O.3
-
32
-
-
77955056692
-
Stable seroepidemiology of hepatitis B after universal immunization in Taiwan: A 3-year study of national surveillance of primary school students
-
Chen CY, Hsu HY, Liu CC, et al. Stable seroepidemiology of hepatitis B after universal immunization in Taiwan: a 3-year study of national surveillance of primary school students. Vaccine 2010;28(34): 5605-8
-
(2010)
Vaccine
, vol.28
, Issue.34
, pp. 5605-5608
-
-
Chen, C.Y.1
Hsu, H.Y.2
Liu, C.C.3
-
33
-
-
33749034174
-
Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization
-
Ch ongsrisawat V, Yoocharoen P, Theamboonlers A, et al. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health 2006; 11(10):1496-502
-
(2006)
Trop Med Int Health
, vol.11
, Issue.10
, pp. 1496-1502
-
-
Chongsrisawat, V.1
Yoocharoen, P.2
Theamboonlers, A.3
-
34
-
-
84890564735
-
A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination
-
Nguyen TH, Vu MH, Nguyen VC, et al. A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination. Vaccine 2014;32( 2):217-22
-
(2014)
Vaccine
, vol.32
, Issue.2
, pp. 217-222
-
-
Nguyen, T.H.1
Vu, M.H.2
Nguyen, V.C.3
-
35
-
-
79551470591
-
Seroprevalence of markers for hepatitis B viral infection
-
Merrill RM, Hunter BD. Seroprevalence of markers for hepatitis B viral infection. Int J Infect Dis 2011;15(2):e78-121
-
(2011)
Int J Infect Dis
, vol.15
, Issue.2
, pp. e78-121
-
-
Merrill, R.M.1
Hunter, B.D.2
-
36
-
-
0036353208
-
Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds
-
Edstam JS, Dulmaa N, Nymadawa P, et a l. Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds. Prev Med 2002; 34(2):207-14
-
(2002)
Prev Med
, vol.34
, Issue.2
, pp. 207-214
-
-
Edstam, J.S.1
Dulmaa, N.2
Nymadawa, P.3
-
38
-
-
84866346428
-
Minimization of hepatitis B infection by a 25-year universal vaccination program
-
Ni YH, Chang MH, Wu JF, et al. Minimization of hepatitis B infection by a 25-year universal vaccination program. J Hepatol 2012;57(4):730-5
-
(2012)
J Hepatol
, vol.57
, Issue.4
, pp. 730-735
-
-
Ni, Y.H.1
Chang, M.H.2
Wu, J.F.3
-
39
-
-
84862957325
-
Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period
-
Luo Z, Li L, Ruan B. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period. Int J Infect Dis 2012;16(2): e82-8
-
(2012)
Int J Infect Dis
, vol.16
, Issue.2
, pp. e82-e88
-
-
Luo, Z.1
Li, L.2
Ruan, B.3
-
40
-
-
79953861295
-
Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region
-
Poovorawan Y, Chongsrisawat V, Theamboonl ers A, et al. Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region. J Viral Hepat 2011;18(5):369-75
-
(2011)
J Viral Hepat
, vol.18
, Issue.5
, pp. 369-375
-
-
Poovorawan, Y.1
Chongsrisawat, V.2
Theamboonlers, A.3
-
41
-
-
50949118651
-
Statements from the Taormina expert meeting on occult hepatitis B virus infection
-
Raimondo G, Allain JP, Brunetto MR, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008;49(4):652-7
-
(2008)
J Hepatol
, vol.49
, Issue.4
, pp. 652-657
-
-
Raimondo, G.1
Allain, J.P.2
Brunetto, M.R.3
-
42
-
-
58149460672
-
Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan
-
Mu SC, Lin YM, Jow GM, Chen BF. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol 2009;50(2):264-72
-
(2009)
J Hepatol
, vol.50
, Issue.2
, pp. 264-272
-
-
Mu, S.C.1
Lin, Y.M.2
Jow, G.M.3
Chen, B.F.4
-
43
-
-
84865126109
-
High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG
-
Shahmoradi S, Yahyapo ur Y, Mahmoodi M, et al. High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG. J Hepatol 2012;57(3):515-21
-
(2012)
J Hepatol
, vol.57
, Issue.3
, pp. 515-521
-
-
Shahmoradi, S.1
Yahyapour, Y.2
Mahmoodi, M.3
-
44
-
-
84885448090
-
Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: A randomized controlled trial
-
Pande C, Sarin SK, Patra S, et al. Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial. J Viral Hepat 2013;20(11):801-10
-
(2013)
J Viral Hepat
, vol.20
, Issue.11
, pp. 801-810
-
-
Pande, C.1
Sarin, S.K.2
Patra, S.3
-
45
-
-
84881499458
-
Occult hepatitis B virus infection in anti-HBs-positive infants born to HBsAg-positive mothers in China
-
Su H, Zhang Y, Xu D, et al. Occult hepatitis B virus infection in anti-HBs-positive infants born to HBsAg-positive mothers in China. PLoS One 2013;8(8):e70768
-
(2013)
PLoS One
, vol.8
, Issue.8
, pp. e70768
-
-
Su, H.1
Zhang, Y.2
Xu, D.3
-
46
-
-
84892711842
-
Occult hepatitis B virus infection and hepatocellular carcinoma: A systematic review
-
Huang X, Hollinger FB. Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review. J Viral Hepat 2014; 21(3):153-62
-
(2014)
J Viral Hepat
, vol.21
, Issue.3
, pp. 153-162
-
-
Huang, X.1
Hollinger, F.B.2
-
47
-
-
34447647679
-
Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes
-
Kramvis A, Kew MC. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res 2007;37(s1):S9-S19
-
(2007)
Hepatol Res
, vol.37
, Issue.S1
, pp. S9-S19
-
-
Kramvis, A.1
Kew, M.C.2
-
48
-
-
0029943782
-
Seroepidemiological survey of hepatitis B and C virus infections in Ghanaian children
-
Martinson FE, Weig le KA, Mushahwar IK, et al. Seroepidemiological survey of hepatitis B and C virus infections in Ghanaian children. J Med Virol 1996;48(3):278-83
-
(1996)
J Med Virol
, vol.48
, Issue.3
, pp. 278-283
-
-
Martinson, F.E.1
Weig Le, K.A.2
Mushahwar, I.K.3
-
49
-
-
0033039255
-
Prevalence and mother-to-infant transmission of hepatitis viruses B,C, and e in Southern Tanzania
-
Menendez C, Sanchez-Tapias JM, Kahigw a E, et al. Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol 1999;58(3):215-20
-
(1999)
J Med Virol
, vol.58
, Issue.3
, pp. 215-220
-
-
Menendez, C.1
Sanchez-Tapias, J.M.2
Kahigw, A.E.3
-
50
-
-
0037443552
-
The risk of hepatitis B virus infection by transfusion in Kumasi
-
Allain JP, Candotti D, Soldan K, et al. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 2003; 101(6):2419-25
-
(2003)
Ghana. Blood
, vol.101
, Issue.6
, pp. 2419-2425
-
-
Allain, J.P.1
Candotti, D.2
Soldan, K.3
-
51
-
-
0142027091
-
Epidemiologic evaluation of the immunity against hepatitis B in Alexandria, Egypt
-
Reda AA,Arafa M.A.,Youssry AA,et al., Epidemiologic evaluation of the immunity against hepatitis B in Alexandria, Egypt, Eur J Epidemiol, 2003, 18, 10, 1007-11.
-
(2003)
Eur J Epidemiol
, vol.18
, Issue.10
, pp. 1007-1011
-
-
Reda, A.A.1
Arafa, M.A.2
Youssry, A.A.3
-
52
-
-
84892164291
-
Efficacy and effectiveness of infant vaccination against chronic hepatitis b in the gambia hepatitis intervention study (1986-90) and in the nationwide immunisation program
-
Peto TJ, Mendy ME, Lowe Y, et al. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986 -90) and in the nationwide immunisation program. BMC Infect Dis 2014;14:7
-
(2014)
BMC Infect Dis
, vol.14
, pp. 7
-
-
Peto, T.J.1
Mendy, M.E.2
Lowe, Y.3
-
53
-
-
77955604248
-
Hepatitis B virus i nfections in apparently healthy urban Nigerians: Data from pre-vaccination tests
-
Adoga MP, Gyar SD, Pechulano S, et al. Hepatitis B virus i nfections in apparently healthy urban Nigerians: data from pre-vaccination tests. J Infect Dev Ctries 2010;4(6):397-400
-
(2010)
J Infect Dev Ctries
, vol.4
, Issue.6
, pp. 397-400
-
-
Adoga, M.P.1
Gyar, S.D.2
Pechulano, S.3
-
54
-
-
56949108483
-
Reduced detection and le vels of protective antibodies to hepatitis B vaccine in under 2-year-old HIV positive South African children at a paediatric outpatient clinic
-
Simani OE, Leroux-Roels G, Francois G, et al. Reduced detection and le vels of protective antibodies to hepatitis B vaccine in under 2-year-old HIV positive South African children at a paediatric outpatient clinic. Vaccine 2009;27(1):146-51
-
(2009)
Vaccine
, vol.27
, Issue.1
, pp. 146-151
-
-
Simani, O.E.1
Leroux-Roels, G.2
Francois, G.3
-
55
-
-
84905120317
-
Seroprevalence of hepatitis B and C viruses among children in kilimanjaro region, tanzania
-
Muro FJ, Fiorillo SP, Sak asaka P, et al. Seroprevalence of hepatitis B and C viruses among children in kilimanjaro region, tanzania. J Pediatric Infect Dis Soc 2013; 2(4):320-6
-
(2013)
J Pediatric Infect Dis Soc
, vol.2
, Issue.4
, pp. 320-326
-
-
Muro, F.J.1
Fiorillo, S.P.2
Sakasaka, P.3
-
56
-
-
84881056381
-
High burden of hepatitis B infection in Northern Uganda: Results of a population-based survey
-
Ochola E, Ocama P, Orach CG, et al. High burden of hepatitis B infection in Northern Uganda: results of a population-based survey. BMC Public Health 2013;13:727
-
(2013)
BMC Public Health
, vol.13
, pp. 727
-
-
Ochola, E.1
Ocama, P.2
Orach, C.G.3
-
58
-
-
84857358267
-
Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
-
Ott JJ, Stevens GA, Groeger J, Wiersma ST . Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012;30(12):2212-19
-
(2012)
Vaccine
, vol.30
, Issue.12
, pp. 2212-2219
-
-
Ott, J.J.1
Stevens, G.A.2
Groeger, J.3
Wiersma, S.T.4
-
59
-
-
84871382671
-
Control of viral hepatitis infection in Africa: Are we dreaming
-
Mihigo R, Nshimirimana D, Hall A, et al. Control of viral hepatitis infection in Africa: are we dreaming? Vaccine 2013;31(2):341-6
-
(2013)
Vaccine
, vol.31
, Issue.2
, pp. 341-346
-
-
Mihigo, R.1
Nshimirimana, D.2
Hall, A.3
-
60
-
-
33750978162
-
Chronic hepatitis B: Current epidemiology in the Americas and implications for management
-
Gish RG, Gadano AC. Chronic hepatitis B: current epidemiology in the Americas and implications for management. J Viral Hepat 2006;13(12):787-98
-
(2006)
J Viral Hepat
, vol.13
, Issue.12
, pp. 787-798
-
-
Gish, R.G.1
Gadano, A.C.2
-
61
-
-
0033966593
-
Hepatitis B epidemiology in Latin America
-
Tanaka J. Hepatitis B epidemiology in Latin America. Vaccine 2000;18(Suppl 1):S17-19
-
(2000)
Vaccine
, vol.18
, pp. S17-19
-
-
Tanaka, J.1
-
63
-
-
79952220557
-
Hepatitis B virus in the United States: Infection exposure and immunity rates in a nationally representative survey
-
Ioannou GN. Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey. Ann Intern Med 2011;154(5): 319-28
-
(2011)
Ann Intern Med
, vol.154
, Issue.5
, pp. 319-328
-
-
Ioannou, G.N.1
-
64
-
-
84856906571
-
Prevalence of hepatitis a b and c serological markers in children from western mexico
-
Escobedo-Melendez G, Fierro NA, Roman S, et al. Prevalence of hepatitis A, B and C serological markers in children from western Mexico. Ann Hepatol 2012;11(2): 194-201
-
(2012)
Ann Hepatol
, vol.11
, Issue.2
, pp. 194-201
-
-
Escobedo-Melendez, G.1
Fierro, N.A.2
Roman, S.3
-
65
-
-
84904687236
-
Low prevalence of hepatitis B and C virus markers among children and adolescents
-
Villar LM, Amado LA, de Almeida AJ, et al. Low prevalence of hepatitis B and C virus markers among children and adolescents. Biomed Res Int 2014;2014:324638
-
(2014)
Biomed Res Int
, vol.2014
, pp. 324638
-
-
Villar, L.M.1
Amado, L.A.2
De Almeida, A.J.3
-
66
-
-
84904549754
-
Prevalencia de la infección por el virus de hepatitis B en nin?os menores de 5 an?os de c omunidades indgenas de la Amazon?á peruana posterior a intervenciones mediante inmunización
-
Cabezas-Sá nchez C, Trujillo-Villarroel O, Zavaleta-Cortijo C, et al. Prevalencia de la infección por el virus de hepatitis B en nin?os menores de 5 an?os de c omunidades indgenas de la Amazon?á peruana posterior a intervenciones mediante inmunización. Rev Peru Med Exp Salud Publica 2014;31: 204-10
-
(2014)
Rev Peru Med Exp Salud Publica
, vol.31
, pp. 204-210
-
-
Cabezas-Sánchez, C.1
Trujillo-Villarroel, O.2
Zavaleta-Cortijo, C.3
-
67
-
-
84902650882
-
Hepatitis B virus infection in Latin America: A genomic medicine approach
-
Roman S, Jose-Abrego A, Fierro NA, et al. Hepatitis B virus infection in Latin America: a genomic medicine approach. World J Gastroenterol 2014;20(23):7181-96
-
(2014)
World J Gastroenterol
, vol.20
, Issue.23
, pp. 7181-7196
-
-
Roman, S.1
Jose-Abrego, A.2
Fierro, N.A.3
-
68
-
-
84907208328
-
High prevalence of occul t hepatitis B virus genotype H infection among children with clinical hepatitis in west Mexico
-
Escobedo-Melendez G, Panduro A, Fierro NA, Roman S. High prevalence of occul t hepatitis B virus genotype H infection among children with clinical hepatitis in west Mexico. Mem Inst Oswaldo Cruz 2014;109(6):728-37
-
(2014)
Mem Inst Oswaldo Cruz
, vol.109
, Issue.6
, pp. 728-737
-
-
Escobedo-Melendez, G.1
Panduro, A.2
Fierro, N.A.3
Roman, S.4
-
69
-
-
84924712349
-
-
Pan Americam Health Organization. World hepatitis day. Hepatitis vaccinati on in latin america and the caribbean Available from Last accessed on 23 November 2014
-
Pan Americam Health Organization. World hepatitis day. Hepatitis vaccinati on in latin america and the caribbean. 2012. Available from: www.paho.org/hq/index.php? option=com-docman&task=doc-view&gid=18239&Itemid= [Last accessed on 23 November 2014]
-
(2012)
-
-
-
70
-
-
67650486243
-
A comparison of hepatitis B seroepidemiology in ten European countries
-
Nardone A, Anastassopoulou CG, Theeten H, et al. A comparison of hepatitis B seroepidemiology in ten European countries. Epidemiol Infect 2009;137(7): 961-9
-
(2009)
Epidemiol Infect
, vol.137
, Issue.7
, pp. 961-969
-
-
Nardone, A.1
Anastassopoulou, C.G.2
Theeten, H.3
-
71
-
-
0141605820
-
Changing epidemiology of HBV infection in Danish children
-
Gjorup IE , Skinhoj P, Bottiger B, Plesner AM. Changing epidemiology of HBV infection in Danish children. J Infect 2003;47(3):231-5
-
(2003)
J Infect
, vol.47
, Issue.3
, pp. 231-235
-
-
Gjorup, I.E.1
Skinhoj, P.2
Bottiger, B.3
Plesner, A.M.4
-
72
-
-
78650797958
-
He patitis B virus infections among children and adolescents in Germany: Migration background as a risk factor in a low seroprevalence population
-
Cai W,Poethko-Muller C,Hamouda O,Radun D., He patitis B virus infections among children and adolescents in Germany: migration background as a risk factor in a low seroprevalence population, Pediatr Infect Dis J, 2011, 30, 1, 19-24.
-
(2011)
Pediatr Infect Dis J
, vol.30
, Issue.1
, pp. 19-24
-
-
Cai, W.1
Poethko-Muller, C.2
Hamouda, O.3
Radun, D.4
-
73
-
-
78649265834
-
Changes in the epidemiology of hepatitis B virus infection following the implementation of immunisation programmes in northeastern Greece
-
pii 19297
-
Zacharakis G, Kotsiou S, Papoutselis M, et al. Changes in the epidemiology of hepatitis B virus infection following the implementation of immunisation programmes in northeastern Greece. Euro Surveill 2009;14(32):pii: 19297
-
(2009)
Euro Surveill
, vol.14
, Issue.32
-
-
Zacharakis, G.1
Kotsiou, S.2
Papoutselis, M.3
-
74
-
-
0342905145
-
Changes in the seroepidemiology of hepatitis B infection in Catalonia 1989-1996
-
Dominguez A, Bruguera M, Vidal J, et al. Changes in the seroepidemiology of hepatitis B infection in Catalonia 1989-1996. Vaccine 2000;18(22):2345-50
-
(2000)
Vaccine
, vol.18
, Issue.22
, pp. 2345-2350
-
-
Dominguez, A.1
Bruguera, M.2
Vidal, J.3
-
75
-
-
83155163799
-
Age-and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: A systematic review
-
Toy M, Onder FO, Worm ann T, et al. Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC Infect Dis 2011;11:337
-
(2011)
BMC Infect Dis
, vol.11
, pp. 337
-
-
Toy, M.1
Onder, F.O.2
Wormann, T.3
-
76
-
-
0032146412
-
Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period
-
Bortolotti F, Jara P, Crivellaro C, et al. Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. J Hepatol 1998;29(2): 184-90
-
(1998)
J Hepatol
, vol.29
, Issue.2
, pp. 184-190
-
-
Bortolotti, F.1
Jara, P.2
Crivellaro, C.3
-
77
-
-
0036681669
-
Long-term follow-up of chronic hepatitis B virus infection in children of different ethnic origins
-
Marx G, Martin SR, Chicoine JF, Alvarez F . Long-term follow-up of chronic hepatitis B virus infection in children of different ethnic origins. J Infect Dis 2002;186(3):295-301
-
(2002)
J Infect Dis
, vol.186
, Issue.3
, pp. 295-301
-
-
Marx, G.1
Martin, S.R.2
Chicoine, J.F.3
Alvarez, F.4
-
78
-
-
4444277933
-
Natural history of hepatitis B in perinatally infected carriers
-
Boxall EH, Sira J, Standish RA, et al. Natural history of hepatitis B in perinatally infected carriers. Arch Dis Child Fetal Neonatal Ed 2004;89(5):F456-60
-
(2004)
Arch Dis Child Fetal Neonatal Ed
, vol.89
, Issue.5
, pp. F456-F460
-
-
Boxall, E.H.1
Sira, J.2
Standish, R.A.3
-
79
-
-
1542721034
-
The development of hepatoc ellular carcinoma among prospectively followed children with chronic hepatitis B virus infection
-
Wen WH, Chang MH, Hsu HY, et al. The development of hepatoc ellular carcinoma among prospectively followed children with chronic hepatitis B virus infection. J Pediatr 2004;144(3):397-9
-
(2004)
J Pediatr
, vol.144
, Issue.3
, pp. 397-399
-
-
Wen, W.H.1
Chang, M.H.2
Hsu, H.Y.3
-
80
-
-
13944257045
-
Chronic hepatit is B infection: Long term comparison of children receiving interferon alpha and untreated controls
-
Vo Thi Diem H, Bourgois A, Bontems P, et al. Chronic hepatit is B infection: long term comparison of children receiving interferon alpha and untreated controls. J Pediatr Gastroenterol Nutr 2005;40(2): 141-5
-
(2005)
J Pediatr Gastroenterol Nutr
, vol.40
, Issue.2
, pp. 141-145
-
-
Vo Thi Diem, H.1
Bourgois, A.2
Bontems, P.3
-
81
-
-
33846079749
-
Natural history of chronic hepatitis B virus infection in children of different ethnic origins: A cohort study with up to 12 years' follow-up in northern Greece
-
Zacharakis G, Koskinas J, Kotsiou S, et al. Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years' follow-up in northern Greece. J Pediatr Gastroenterol Nutr 2007;44(1):84-91
-
(2007)
J Pediatr Gastroenterol Nutr
, vol.44
, Issue.1
, pp. 84-91
-
-
Zacharakis, G.1
Koskinas, J.2
Kotsiou, S.3
-
82
-
-
34848884493
-
Long-term outcome in children with chronic hepatitis B: A 24-year observation period
-
Iorio R, Giannattasio A, Cirillo F, et al. Long-term outcome in children with chronic hepatitis B: a 24-year observation period. Clin Infect Dis 2007;45(8):943-9
-
(2007)
Clin Infect Dis
, vol.45
, Issue.8
, pp. 943-949
-
-
Iorio, R.1
Giannattasio, A.2
Cirillo, F.3
-
84
-
-
84875218851
-
Chronic hepatitis B virus (HBV) infection in children: 25 years' experience
-
Popalis C, Yeung LT, Ling SC, et al. Chronic hepatitis B virus (HBV) infection in children: 25 years' experience. J Viral Hepat 2013;20(4):e20-6
-
(2013)
J Viral Hepat
, vol.20
, Issue.4
, pp. e20-e26
-
-
Popalis, C.1
Yeung, L.T.2
Ling, S.C.3
-
86
-
-
0019988637
-
Hepatitis-B virus infection in black children with hepatocellular carcinoma
-
Kew MC, Hodkinson J, Paterson AC, Song E. Hepatitis-B virus infection in black children with hepatocellular carcinoma. J Med Virol 1982;9(3):201-7
-
(1982)
J Med Virol
, vol.9
, Issue.3
, pp. 201-207
-
-
Kew, M.C.1
Hodkinson, J.2
Paterson, A.C.3
Song, E.4
-
87
-
-
0023193115
-
Childhood hepatocel lular carcinoma develops exclusively in hepatitis B surface antigen carriers in three decades in Taiwan. Report of 51 cases strongly associated with rapid development of liver cirrhosis
-
Hsu HC, Wu MZ, Chang MH, et al. Childhood hepatocel lular carcinoma develops exclusively in hepatitis B surface antigen carriers in three decades in Taiwan. Report of 51 cases strongly associated with rapid development of liver cirrhosis. J Hepatol 1987;5(3):260-7
-
(1987)
J Hepatol
, vol.5
, Issue.3
, pp. 260-267
-
-
Hsu, H.C.1
Wu, M.Z.2
Chang, M.H.3
-
88
-
-
0024437718
-
Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma
-
Chang MH, Chen DS, Hsu HC, et al. Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma. Cancer 1989;64(11):2377-80
-
(1989)
Cancer
, vol.64
, Issue.11
, pp. 2377-2380
-
-
Chang, M.H.1
Chen, D.S.2
Hsu, H.C.3
-
89
-
-
0025014833
-
Childhood primary hepatocellular carcinoma and hepatitis B virus infection
-
Cheah PL, Looi LM, Lin HP , Yap SF. Childhood primary hepatocellular carcinoma and hepatitis B virus infection. Cancer 1990;65(1):174-6
-
(1990)
Cancer
, vol.65
, Issue.1
, pp. 174-176
-
-
Cheah, P.L.1
Looi, L.M.2
Lin, H.P.3
Yap, S.F.4
-
90
-
-
0026864703
-
Hepatocellular carcinoma in children with hepatitis B surface antigen
-
Tazawa Y, Nishinomiya F, Noguchi H, et al. Hepatocellular carcinoma in children with hepatitis B surface antigen. Tohoku J Exp Med 1992;167(1):47-55
-
(1992)
Tohoku J Exp Med
, vol.167
, Issue.1
, pp. 47-55
-
-
Tazawa, Y.1
Nishinomiya, F.2
Noguchi, H.3
-
91
-
-
0034948184
-
Hepatocellular carcinoma in Nigerian children
-
Akinyinka OO, Falade AG, Ogunbiyi O, Johnson AO. Hepatocellular carcinoma in Nigerian children. Ann Trop Paediatr 2001; 21(2):165-8
-
(2001)
Ann Trop Paediatr
, vol.21
, Issue.2
, pp. 165-168
-
-
Akinyinka, O.O.1
Falade, A.G.2
Ogunbiyi, O.3
Johnson, A.O.4
-
92
-
-
3242760687
-
Hepatocellular carcinoma and liver tumors in South African children: A case for increased prevalence
-
Moore SW, Millar AJ, Hadley GP, et al. Hepatocellular carcinoma and liver tumors in South African children: a case for increased prevalence. Cancer 2004;101(3): 642-9
-
(2004)
Cancer
, vol.101
, Issue.3
, pp. 642-649
-
-
Moore, S.W.1
Millar, A.J.2
Hadley, G.P.3
-
93
-
-
33745220552
-
Profile of chronic hepatitis B virus in children in India: Experience with 116 children
-
Satapathy SK, Garg S, Chauhan R, et al. Profile of chronic hepatitis B virus in children in India: experience with 116 children. J Gastroenterol Hepatol 2006; 21(7):1170-6
-
(2006)
J Gastroenterol Hepatol
, vol.21
, Issue.7
, pp. 1170-1176
-
-
Satapathy, S.K.1
Garg, S.2
Chauhan, R.3
-
94
-
-
84881094845
-
Clinical characteristics and outcome of hepatocellular carcinoma in children and adolescents
-
Zhang XF,Liu XM,Wei T,et al. Clinical characteristics and outcome of hepatocellular carcinoma in children and adolescents. Pediatr Surg Int 2013, 29, 8, 763-70.
-
(2013)
Pediatr Surg Int
, vol.29
, Issue.8
, pp. 763-770
-
-
Zhang, X.F.1
Liu, X.M.2
Wei, T.3
-
95
-
-
34250020201
-
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
-
El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132(7):2557-76
-
(2007)
Gastroenterology
, vol.132
, Issue.7
, pp. 2557-2576
-
-
El-Serag, H.B.1
Rudolph, K.L.2
-
96
-
-
77953724339
-
The changing pattern of epidemiology in hepatocellular carcinoma
-
Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 2010;42(Suppl 3):S206-214
-
(2010)
Dig Liver Dis
, vol.42
, pp. S206-214
-
-
Nordenstedt, H.1
White, D.L.2
El-Serag, H.B.3
-
97
-
-
84875353456
-
Aflatoxins, hepatocellular carcinoma and public health
-
Magnussen A, Parsi MA. Aflatoxins, hepatocellular carcinoma and public health. World J Gastroenterol 2013;19(10):1508-12
-
(2013)
World J Gastroenterol
, vol.19
, Issue.10
, pp. 1508-1512
-
-
Magnussen, A.1
Parsi, M.A.2
-
98
-
-
77954642729
-
Management of chronic hepatitis b in pregnancy
-
Buchanan C, Tran TT. Management of chronic hepatitis B in pregnancy. Clin Liver Dis 2010;14(3):495-504
-
(2010)
Clin Liver Dis
, vol.14
, Issue.3
, pp. 495-504
-
-
Buchanan, C.1
Tran, T.T.2
-
99
-
-
32844458617
-
Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: Systematic review and meta-analysis
-
Lee C, Gong Y, Brok J, et al. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 2006;332(7537): 328-36
-
(2006)
BMJ
, vol.332
, Issue.7537
, pp. 328-336
-
-
Lee, C.1
Gong, Y.2
Brok, J.3
-
100
-
-
0021086531
-
Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine
-
Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983;2(8359):1099-102
-
(1983)
Lancet
, vol.2
, Issue.8359
, pp. 1099-1102
-
-
Beasley, R.P.1
Hwang, L.Y.2
Lee, G.C.3
-
101
-
-
77958102964
-
Hepatitis B therapy in pregnancy
-
Bzowej NH. Hepatitis B therapy in pregnancy. Curr Hepat Rep 2010;9(4): 197-204
-
(2010)
Curr Hepat Rep
, vol.9
, Issue.4
, pp. 197-204
-
-
Bzowej, N.H.1
-
102
-
-
67649208402
-
Perinatal transmission of hepatitis B virus: An Australian experience
-
Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009; 190(9):489-92
-
(2009)
Med J Aust
, vol.190
, Issue.9
, pp. 489-492
-
-
Wiseman, E.1
Fraser, M.A.2
Holden, S.3
-
103
-
-
84862777352
-
An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus
-
Pan CQ, Duan ZP, Bhamidimarri KR, et al. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol 2012;10(5):452-9
-
(2012)
Clin Gastroenterol Hepatol
, vol.10
, Issue.5
, pp. 452-459
-
-
Pan, C.Q.1
Duan, Z.P.2
Bhamidimarri, K.R.3
-
104
-
-
84908356413
-
A study of immunoprophylaxis failure and risk factors of hepatitis B virus mother-to-infant transmission
-
Zhang L, Gui X, Wang B, et al. A study of immunoprophylaxis failure and risk factors of hepatitis B virus mother-to-infant transmission. Eur J Pediatr 2014;173(9): 1161-8
-
(2014)
Eur J Pediatr
, vol.173
, Issue.9
, pp. 1161-1168
-
-
Zhang, L.1
Gui, X.2
Wang, B.3
-
105
-
-
84855822878
-
Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers
-
Zou H, Chen Y, Duan Z, et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive moth ers. J Viral Hepat 2012;19(2):e18-25
-
(2012)
J Viral Hepat
, vol.19
, Issue.2
, pp. e18-25
-
-
Zou, H.1
Chen, Y.2
Duan, Z.3
-
106
-
-
79959587851
-
Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants
-
Singh AE, Plitt SS, Osiowy C, et al. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat 2011;18(7):468-73
-
(2011)
J Viral Hepat
, vol.18
, Issue.7
, pp. 468-473
-
-
Singh, A.E.1
Plitt, S.S.2
Osiowy, C.3
-
107
-
-
84984586986
-
Mother-to-infant transmission of hepatitis B virus infection: Significance of maternal viral load and strateg ies for intervention
-
Wen WH, Chang MH, Zhao LL, et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strateg ies for intervention. J Hepatol 2013;59(1):24-30
-
(2013)
J Hepatol
, vol.59
, Issue.1
, pp. 24-30
-
-
Wen, W.H.1
Chang, M.H.2
Zhao, L.L.3
-
108
-
-
59149096271
-
Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: A multicentre, randomized, double-blind, placebo-controlled study
-
Xu WM, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009;16(2):94-103
-
(2009)
J Viral Hepat
, vol.16
, Issue.2
, pp. 94-103
-
-
Xu, W.M.1
Cui, Y.T.2
Wang, L.3
-
109
-
-
84891460915
-
Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection
-
Celen MK, Mert D, Ay M, et al. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection. World J Gastroenterol 2013;19(48):9377-82
-
(2013)
World J Gastroenterol
, vol.19
, Issue.48
, pp. 9377-9382
-
-
Celen, M.K.1
Mert, D.2
Ay, M.3
-
110
-
-
84906314968
-
Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus
-
Greenup AJ, Tan PK, Nguyen V, et al. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. J Hepatol 2014;61(3):502-7
-
(2014)
J Hepatol
, vol.61
, Issue.3
, pp. 502-507
-
-
Greenup, A.J.1
Tan, P.K.2
Nguyen, V.3
-
111
-
-
81355161368
-
A prospective and open-label study for the efficacy and safet y of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection
-
Han GR, Cao MK, Zhao W, et al. A prospective and open-label study for the efficacy and safet y of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 2011;55(6):1215-21
-
(2011)
J Hepatol
, vol.55
, Issue.6
, pp. 1215-1221
-
-
Han, G.R.1
Cao, M.K.2
Zhao, W.3
-
112
-
-
84862776962
-
Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B
-
Pan CQ, Han GR, Jiang HX, et al. Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B. Clin Gastroenterol Hepatol 2012;10(5):520-6
-
(2012)
Clin Gastroenterol Hepatol
, vol.10
, Issue.5
, pp. 520-526
-
-
Pan, C.Q.1
Han, G.R.2
Jiang, H.X.3
-
113
-
-
84905117611
-
Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus
-
Yu MM, Jiang Q, Ji Y, et al. Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus. J Clin Virol 2014;61(1): 55-60
-
(2014)
J Clin Virol
, vol.61
, Issue.1
, pp. 55-60
-
-
Yu, M.M.1
Jiang, Q.2
Ji, Y.3
-
114
-
-
84901637984
-
Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice
-
Zhang H, Pan CQ, Pang Q, et al. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. Hepatology 2014;60(2):468-76
-
(2014)
Hepatology
, vol.60
, Issue.2
, pp. 468-476
-
-
Zhang, H.1
Pan, C.Q.2
Pang, Q.3
-
115
-
-
0042565827
-
Interruption of HBV intrauterine transmission: A clinical study
-
Li XM,Yang YB,Hou HY,et al., Interruption of HBV intrauterine transmission: a clinical study, World J Gastroenterol, 2003, 9, 7, 1501-3.
-
(2003)
World J Gastroenterol
, vol.9
, Issue.7
, pp. 1501-1503
-
-
Li, X.M.1
Yang, Y.B.2
Hou, H.Y.3
-
116
-
-
0038003144
-
Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection
-
van Zonneveld M, van Nunen AB, Niesters HG, et al. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003;10(4):294-7
-
(2003)
J Viral Hepat
, vol.10
, Issue.4
, pp. 294-297
-
-
Van Zonneveld, M.1
Van Nunen, A.B.2
Niesters, H.G.3
-
117
-
-
0034083125
-
Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients
-
van Nunen AB, de Man RA, Heijtink RA, et al. Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients. J Hepatol 2000;32(6):1040-1
-
(2000)
J Hepatol
, vol.32
, Issue.6
, pp. 1040-1041
-
-
Van Nunen, A.B.1
De Man, R.A.2
Heijtink, R.A.3
-
118
-
-
80955149605
-
A meta-analysis of lamiv udine for interruption of mother-to-child transmission of hepatitis B virus
-
Han L, Zhang HW, Xie JX, et al. A meta-analysis of lamiv udine for interruption of mother-to-child transmission of hepatitis B virus. World J Gastroenterol 2011;17(38):4321-33
-
(2011)
World J Gastroenterol
, vol.17
, Issue.38
, pp. 4321-4333
-
-
Han, L.1
Zhang, H.W.2
Xie, J.X.3
-
119
-
-
84904675383
-
Ending vertical transmission of hepatitis B: The third trimester intervention
-
Sarkar M, Terrault NA. Ending vertical transmission of hepatitis B: the third trimester intervention. Hepatology 2014; 60(2):448-51
-
(2014)
Hepatology
, vol.60
, Issue.2
, pp. 448-451
-
-
Sarkar, M.1
Terrault, N.A.2
-
120
-
-
84878855035
-
Antiviral therapy for chronic hepatitis B in pregnancy
-
Pan CQ, Lee HM. Antiviral therapy for chronic hepatitis B in pregnancy. Semin Liver Dis 2013;33(2):138-46
-
(2013)
Semin Liver Dis
, vol.33
, Issue.2
, pp. 138-146
-
-
Pan, C.Q.1
Lee, H.M.2
-
121
-
-
84862021770
-
Hepatitis B virus infection and pregnancy: A practical approach
-
Kumar A . Hepatitis B virus infection and pregnancy: a practical approach. Indian J Gastroenterol 2012;31(2):43-54
-
(2012)
Indian J Gastroenterol
, vol.31
, Issue.2
, pp. 43-54
-
-
Kumar, A.1
-
122
-
-
37349120537
-
Telbivudine versus lamivudine in patients with chronic hepatitis B
-
Lai CL, Gane E, Liaw YF, et al. Telbivudine versus lamivudine in patients with chronic hepatitis B. N Engl J Med 2007;357(25):2576-88
-
(2007)
N Engl J Med
, vol.357
, Issue.25
, pp. 2576-2588
-
-
Lai, C.L.1
Gane, E.2
Liaw, Y.F.3
-
123
-
-
58649096155
-
2-Year GLOBE trial results: Telbivudine Is superior to lamivudine in patients with chronic hepa titis B
-
Liaw YF, Gane E, Leung N, et al. 2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepa titis B. Gastroenterology 2009;136(2): 486-95
-
(2009)
Gastroenterology
, vol.136
, Issue.2
, pp. 486-495
-
-
Liaw, Y.F.1
Gane, E.2
Leung, N.3
-
124
-
-
84872024331
-
Optimal management of HBV infection during pregnancy
-
Piratvisuth T. Optimal management of HBV infection during pregnancy. Liver Int 2013;33(Suppl 1):188-94
-
(2013)
Liver Int
, vol.33
, pp. 188-194
-
-
Piratvisuth, T.1
-
125
-
-
84926222332
-
Hepatitis B and C in pregnancy: A review and recommendations for care
-
Dunkelberg JC, Berkley EM, Thiel KW, Leslie KK. Hepatitis B and C in pregnancy: a review and recommendations for care. J Perinatol 2014;34(12):882-91
-
(2014)
J Perinatol
, vol.34
, Issue.12
, pp. 882-891
-
-
Dunkelberg, J.C.1
Berkley, E.M.2
Thiel, K.W.3
Leslie, K.K.4
-
126
-
-
84867711652
-
Hepatitis B in pregnancy
-
Borgia G, Carleo MA, Gaeta GB, Gentile I. Hepatitis B in pregnancy. World J Gastroenterol 2012;18(34):4677-83
-
(2012)
World J Gastroenterol
, vol.18
, Issue.34
, pp. 4677-4683
-
-
Borgia, G.1
Carleo, M.A.2
Gaeta, G.B.3
Gentile, I.4
-
127
-
-
84884405214
-
Ma nagement of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: Consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition
-
Sokal EM, Paganelli M, Wirth S, et al. Ma nagement of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Hepatol 2013;59(4):814-29.
-
(2013)
J Hepatol
, vol.59
, Issue.4
, pp. 814-829
-
-
Sokal, E.M.1
Paganelli, M.2
Wirth, S.3
-
128
-
-
81355138664
-
HBV treatment and pregnancy
-
Petersen J. HBV treatment and pregnancy. J Hepatol 2011;55(6):1171-3
-
(2011)
J Hepatol
, vol.55
, Issue.6
, pp. 1171-1173
-
-
Petersen, J.1
-
129
-
-
84908023727
-
Short duration of lamivudine for the prevention of he patitis B virus transmission in pregnancy: Lack of potency and selection of resistance mutations
-
Ayres A, Yuen L, Jackson KM, et al. Short duration of lamivudine for the prevention of he patitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations. J Viral Hepat 2014;21(11): 809-17
-
(2014)
J Viral Hepat
, vol.21
, Issue.11
, pp. 809-817
-
-
Ayres, A.1
Yuen, L.2
Jackson, K.M.3
-
130
-
-
0026036070
-
Symptomatic reactivation of hepatitis B in pregnancy
-
Rawal BK, Parida S, Watkins RP, et al. Symptomatic reactivation of hepatitis B in pregnancy. Lancet 1991;337(8737):364
-
(1991)
Lancet
, vol.337
, Issue.8737
, pp. 364
-
-
Rawal, B.K.1
Parida, S.2
Watkins, R.P.3
-
131
-
-
36949012244
-
Exacerbation of chronic hepatitis B infection after delivery
-
ter Borg MJ, Leemans WF, de Man RA, Janssen HL. Exacerbation of chronic hepatitis B infection after delivery. J Viral Hepat 2008;15(1):37-41
-
(2008)
J Viral Hepat
, vol.15
, Issue.1
, pp. 37-41
-
-
Ter Borg, M.J.1
Leemans, W.F.2
De Man, R.A.3
Janssen, H.L.4
-
132
-
-
84865763518
-
Optimal management of the hepatitis b patient who desires pregnancy or is pregnant
-
Bzowej NH. Optimal management of the hepatitis b patient who desires pregnancy or is pregnant. Curr Hepat Rep 2012;11(2): 82-9
-
(2012)
Curr Hepat Rep
, vol.11
, Issue.2
, pp. 82-89
-
-
Bzowej, N.H.1
-
133
-
-
84902312952
-
Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus
-
Gentile I, Zappulo E, Buonomo AR, Borgia G. Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus. Expert Rev Anti Infect Ther 2014;12(7):775-82
-
(2014)
Expert Rev Anti Infect Ther
, vol.12
, Issue.7
, pp. 775-782
-
-
Gentile, I.1
Zappulo, E.2
Buonomo, A.R.3
Borgia, G.4
-
134
-
-
70349240414
-
Chronic hepatitis B: Update 2009
-
Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009;50(3):661-2
-
(2009)
Hepatology
, vol.50
, Issue.3
, pp. 661-662
-
-
Lok, A.S.1
McMahon, B.J.2
-
136
-
-
78649572605
-
Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options
-
Jonas MM,Block JM,Haber BA,et al. Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options. Hepatology 2010, 52, 6, 2192- 205.
-
(2010)
Hepatology
, vol.52
, Issue.6
, pp. 2192-2205
-
-
Jonas, M.M.1
Block, J.M.2
Haber, B.A.3
-
137
-
-
84866346241
-
Chronic hepatitis B in children and adolescents
-
Paganelli M, Stephenne X, Sokal EM. Chronic hepatitis B in children and adolescents. J Hepatol 2012;57(4):885-96
-
(2012)
J Hepatol
, vol.57
, Issue.4
, pp. 885-896
-
-
Paganelli, M.1
Stephenne, X.2
Sokal, E.M.3
-
138
-
-
66149180814
-
Special populations with hepatitis B virus infection
-
Peters MG. Special populations with hepatitis B virus infection. Hepatology 2009;49(5 Suppl):S146-55
-
(2009)
Hepatology
, vol.49
, Issue.5
, pp. S146-S155
-
-
Peters, M.G.1
-
139
-
-
70350519979
-
Recommendations for screening, monitoring, and referral of pediatric chronic hepatitis B
-
Haber BA, Block JM, Jonas MM, et al. Recommendations for screening, monitoring, and referral of pediatric chronic hepatitis B. Pediatrics 2009;124(5): e1007-13
-
(2009)
Pediatrics
, vol.124
, Issue.5
, pp. e1007-e1013
-
-
Haber, B.A.1
Block, J.M.2
Jonas, M.M.3
-
140
-
-
9244231148
-
Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: A multicenter controlled trial
-
Gregorio GV, Jara P, Hierro L, et al. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial. Hepatology 1996;23(4): 700-7
-
(1996)
Hepatology
, vol.23
, Issue.4
, pp. 700-707
-
-
Gregorio, G.V.1
Jara, P.2
Hierro, L.3
-
141
-
-
2442561268
-
Predictors of virologic response to Lamivudine treatment in children with chronic hepatitis B infection
-
Hom X, Little NR, Gardner SD, Jonas MM. Predictors of virologic response to Lamivudine treatment in children with chronic hepatitis B infection. Pediatr Infect Dis J 2004;23(5):441-5
-
(2004)
Pediatr Infect Dis J
, vol.23
, Issue.5
, pp. 441-445
-
-
Hom, X.1
Little, N.R.2
Gardner, S.D.3
Jonas, M.M.4
-
142
-
-
12244310799
-
Histopathology of portal hypertension: A practical guideline
-
Roskams T, Baptista A, Bianchi L, et al. Histopathology of portal hypertension: a practical guideline. Histopathology 2003; 42(1):2-13
-
(2003)
Histopathology
, vol.42
, Issue.1
, pp. 2-13
-
-
Roskams, T.1
Baptista, A.2
Bianchi, L.3
-
143
-
-
0034761964
-
Serum alanine aminotransferase flares during interferon treatment of chronic hepatitis B: Is sustained clearance of HBV DNA dependent on levels of pretreatment viremia
-
Nair S, Perrillo RP. Serum alanine aminotransferase flares during interferon treatment of chronic hepatitis B: is sustained clearance of HBV DNA dependent on levels of pretreatment viremia? Hepatology 2001; 34(5):1021-6
-
(2001)
Hepatology
, vol.34
, Issue.5
, pp. 1021-1026
-
-
Nair, S.1
Perrillo, R.P.2
-
144
-
-
0037366499
-
Hepatitis flares and hepatitis B e antigen seroconversion: Implication in anti-hepatitis B virus therapy
-
Liaw YF. Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy. J Gastroenterol Hepatol 2003;18(3):246-52
-
(2003)
J Gastroenterol Hepatol
, vol.18
, Issue.3
, pp. 246-252
-
-
Liaw, Y.F.1
-
145
-
-
33749447547
-
Treating chronic hepatitis B: Today and tomorrow
-
Borgia G, Gentile I. Treating chronic hepatitis B: today and tomorrow. Curr Med Chem 2006;13(23):2839-55
-
(2006)
Curr Med Chem
, vol.13
, Issue.23
, pp. 2839-2855
-
-
Borgia, G.1
Gentile, I.2
-
146
-
-
0023616670
-
Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children
-
Lai CL, Lok AS, Lin HJ, et al. Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children. Lancet 1987;2(8564):877-80
-
(1987)
Lancet
, vol.2
, Issue.8564
, pp. 877-880
-
-
Lai, C.L.1
Lok, A.S.2
Lin, H.J.3
-
147
-
-
0026044641
-
Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatit is B
-
Ruiz-Moreno M, Rua MJ, Molina J, et al. Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatit is B. Hepatology 1991;13(6):1035-9
-
(1991)
Hepatology
, vol.13
, Issue.6
, pp. 1035-1039
-
-
Ruiz-Moreno, M.1
Rua, M.J.2
Molina, J.3
-
148
-
-
0025732216
-
Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: A controlled, ra ndomized study
-
Utili R, Sagnelli E, Galanti B, et al. Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, ra ndomized study. Am J Gastroenterol 1991;86(3): 327-30
-
(1991)
Am J Gastroenterol
, vol.86
, Issue.3
, pp. 327-330
-
-
Utili, R.1
Sagnelli, E.2
Galanti, B.3
-
149
-
-
0031969612
-
Interferon alfa therapy for chronic hepatitis B in children: A multinational randomize d controlled trial
-
Sokal EM, Conjeevaram HS, Roberts EA, et al. Interferon alfa therapy for chronic hepatitis B in children: a multinational randomize d controlled trial. Gastroenterology 1998;114(5):988-95
-
(1998)
Gastroenterology
, vol.114
, Issue.5
, pp. 988-995
-
-
Sokal, E.M.1
Conjeevaram, H.S.2
Roberts, E.A.3
-
150
-
-
84930484047
-
Treatment of children with HBeAg-positive chronic hepatitis B: A systematic review and meta-analysis
-
El Sherbini A, Omar A. Treatment of children with HBeAg-positive chronic hepatitis B: A systematic review and meta-analysis. Dig Liver Dis 2014;46(12): 1103-10
-
(2014)
Dig Liver Dis
, vol.46
, Issue.12
, pp. 1103-1110
-
-
El Sherbini, A.1
Omar, A.2
-
151
-
-
0034023606
-
Long term effect of alpha interferon in children with chronic hepatitis B
-
Bortolotti F, Jara P, Barbera C, et al. Long term effect of alpha interferon in children with chronic hepatitis B. Gut 2000;46(5): 715-18
-
(2000)
Gut
, vol.46
, Issue.5
, pp. 715-718
-
-
Bortolotti, F.1
Jara, P.2
Barbera, C.3
-
152
-
-
33744963090
-
Long-term follow-up of hepatitis B carrier children treated with interferon and prednisolone
-
Boxall EH, Sira J, Ballard AL, et al. Long-term follow-up of hepatitis B carrier children treated with interferon and prednisolone. J Med Virol 2006;78(7): 888-95
-
(2006)
J Med Virol
, vol.78
, Issue.7
, pp. 888-895
-
-
Boxall, E.H.1
Sira, J.2
Ballard, A.L.3
-
153
-
-
84983724527
-
Interferon-alpha treatment in children and young adults with chronic hepatitis B: A long-term follow-up study in Taiwan
-
Hsu HY , Tsai HY, Wu TC, et al. Interferon-alpha treatment in children and young adults with chronic hepatitis B: a long-term follow-up study in Taiwan. Liver Int 2008;28(9):1288-97
-
(2008)
Liver Int
, vol.28
, Issue.9
, pp. 1288-1297
-
-
Hsu, H.Y.1
Tsai, H.Y.2
Wu, T.C.3
-
154
-
-
0025970995
-
Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children
-
Lai CL, Lin HJ, Lau JN, et al. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children. Q J Med 1991;78(286): 155-63
-
(1991)
Q J Med
, vol.78
, Issue.286
, pp. 155-163
-
-
Lai, C.L.1
Lin, H.J.2
Lau, J.N.3
-
155
-
-
73449085495
-
Current issues in the management of paediatric viral hepatitis
-
Y eung LT, Roberts EA. Current issues in the management of paediatric viral hepatitis. Liver Int 2010;30(1):5-18
-
(2010)
Liver Int
, vol.30
, Issue.1
, pp. 5-18
-
-
Yeung, L.T.1
Roberts, E.A.2
-
156
-
-
84924712348
-
-
Source G Available from Last accessed on 12 November
-
Source G Available from: www.gsksource. com/gskprm/htdocs/documents/EPIVIRHBV- PI-PIL.PDF [Last accessed on 12 November 2014]
-
(2014)
-
-
-
157
-
-
0037198434
-
Clinical trial of lamivudine in children with chronic hepatitis B
-
Jonas MM, Mizerski J, Badia IB, et al. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 2002; 346(22):1706-13
-
(2002)
N Engl J Med
, vol.346
, Issue.22
, pp. 1706-1713
-
-
Jonas, M.M.1
Mizerski, J.2
Badia, I.B.3
-
158
-
-
33644524424
-
Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B
-
Sokal EM,Kelly DA,Mizerski J,et al.,Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B, Hepatology, 2006, 43, 2, 225-32.
-
(2006)
Hepatology
, vol.43
, Issue.2
, pp. 225-232
-
-
Sokal, E.M.1
Kelly, D.A.2
Mizerski, J.3
-
159
-
-
10744221461
-
Current therapeutic approaches in childhood chronic hepatitis B infection: A multicenter study
-
Dikici B, Ozgenc F, Kalayci AG, et al. Current therapeutic approaches in childhood chronic hepatitis B infection: a multicenter study. J Gastroenterol Hepatol 2004;19(2):127-33
-
(2004)
J Gastroenterol Hepatol
, vol.19
, Issue.2
, pp. 127-133
-
-
Dikici, B.1
Ozgenc, F.2
Kalayci, A.G.3
-
160
-
-
11144321331
-
Lamivudine and high-dose interferon-alpha combination therapy for naive children with chronic hepatitis B infection
-
Saltik-Temizel IN, Kocak N, Demir H. Lamivudine and high-dose interferon-alpha combination therapy for naive children with chronic hepatitis B infection. J Clin Gastroenterol 2005;39(1):68-70
-
(2005)
J Clin Gastroenterol
, vol.39
, Issue.1
, pp. 68-70
-
-
Saltik-Temizel, I.N.1
Kocak, N.2
Demir, H.3
-
161
-
-
0347933025
-
Adefovir dipivoxil: A new antiviral agent for the treatment of hepatitis B virus infection
-
Qaqish RB, Matt es KA, Ritchie DJ. Adefovir dipivoxil: a new antiviral agent for the treatment of hepatitis B virus infection. Clin Ther 2003;25(12):3084-99
-
(2003)
Clin Ther
, vol.25
, Issue.12
, pp. 3084-3099
-
-
Qaqish, R.B.1
Mattes, K.A.2
Ritchie, D.J.3
-
162
-
-
46249118136
-
Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to 18 years) with chronic hepatitis B
-
Jonas MM, Kelly D, Pollack H, et al. Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to18 years) with chronic hepatitis B. Hepatology,2008,47,6, 1863-71.
-
(2008)
Hepatology
, vol.47
, Issue.6
, pp. 1863-1871
-
-
Jonas, M.M.1
Kelly, D.2
Pollack, H.3
-
163
-
-
84870934683
-
Virologic responses to add-on adefovir dipivoxil treatment versus entecavir monotherapy in children with lamivudine-resistant chronic hepatitis B
-
Chu M, Cho SM, Choe BH, et al. Virologic responses to add-on adefovir dipivoxil treatment versus entecavir monotherapy in children with lamivudine-resistant chronic hepatitis B. J Pediatr Gastroenterol Nutr 2012;55(6): 648-52
-
(2012)
J Pediatr Gastroenterol Nutr
, vol.55
, Issue.6
, pp. 648-652
-
-
Chu, M.1
Cho, S.M.2
Choe, B.H.3
-
164
-
-
57349095400
-
Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B
-
Marcellin P, Heathcote EJ, Buti M, et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med 2008;359(23):2442-55
-
(2008)
N Engl J Med
, vol.359
, Issue.23
, pp. 2442-2455
-
-
Marcellin, P.1
Heathcote, E.J.2
Buti, M.3
-
165
-
-
0035822988
-
The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: A randomized, placebo-controlled trial
-
Fisher EJ, Chaloner K, Cohn DL, et al. The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial. AIDS 2001;15(13):1695-700
-
(2001)
AIDS
, vol.15
, Issue.13
, pp. 1695-1700
-
-
Fisher, E.J.1
Chaloner, K.2
Cohn, D.L.3
-
166
-
-
0033596267
-
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: A randomized controlled trial
-
Kahn J, Lagakos S, Wulfsohn M, et al. Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. JAMA 1999;282(24): 2305-12
-
(1999)
JAMA
, vol.282
, Issue.24
, pp. 2305-2312
-
-
Kahn, J.1
Lagakos, S.2
Wulfsohn, M.3
-
167
-
-
66149190942
-
Side effects o f long-term oral antiviral therapy for hepatitis B
-
Fontana RJ. Side effects o f long-term oral antiviral therapy for hepatitis B. Hepatology 2009;49(5 Suppl):S185-95
-
(2009)
Hepatology
, vol.49
, Issue.5
, pp. S185-S195
-
-
Fontana, R.J.1
-
168
-
-
84870544889
-
Randomized placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B
-
Murray KF, Szenborn L, Wysocki J, et al. Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B. Hepatology 2012; 56(6):2018-26
-
(2012)
Hepatology
, vol.56
, Issue.6
, pp. 2018-2026
-
-
Murray, K.F.1
Szenborn, L.2
Wysocki, J.3
-
169
-
-
78650477355
-
Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B
-
Heathcote EJ, Marcellin P, Buti M, et al. Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. Gastroenterology 2011;140(1): 132-43
-
(2011)
Gastroenterology
, vol.140
, Issue.1
, pp. 132-143
-
-
Heathcote, E.J.1
Marcellin, P.2
Buti, M.3
-
170
-
-
79952227475
-
No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus
-
Snow-Lampart A, Chappell B, Curtis M, et al. No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus. Hepatology 2011; 53(3):763-73
-
(2011)
Hepatology
, vol.53
, Issue.3
, pp. 763-773
-
-
Snow-Lampart, A.1
Chappell, B.2
Curtis, M.3
-
171
-
-
33646186755
-
Entecavir for the treatment of chronic hepatitis B virus infection
-
Matthews SJ. Entecavir for the treatment of chronic hepatitis B virus infection. Clin Ther 2006;28(2):184-203
-
(2006)
Clin Ther
, vol.28
, Issue.2
, pp. 184-203
-
-
Matthews, S.J.1
-
172
-
-
0031761652
-
In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir
-
Seifer M, Hamatake RK, Colonno RJ, Standring DN. In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir. Antimicrob Agents Chemother 1998;42(12):3200-8
-
(1998)
Antimicrob Agents Chemother
, vol.42
, Issue.12
, pp. 3200-3208
-
-
Seifer, M.1
Hamatake, R.K.2
Colonno, R.J.3
Standring, D.N.4
-
173
-
-
33644818518
-
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
-
Chang TT, Gish RG, de Man R, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 2006;354(10):1001-10
-
(2006)
N Engl J Med
, vol.354
, Issue.10
, pp. 1001-1010
-
-
Chang, T.T.1
Gish, R.G.2
De Man, R.3
-
174
-
-
35649020315
-
Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B
-
Gish RG, Lok AS, Chang TT, et al. Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B. Gastroenterology 2007;133(5): 1437-44
-
(2007)
Gastroenterology
, vol.133
, Issue.5
, pp. 1437-1444
-
-
Gish, R.G.1
Lok, A.S.2
Chang, T.T.3
-
175
-
-
84924712347
-
-
Bristol-Myers Squibb. Available from Last accessed on 12 November
-
Bristol-Myers Squibb. Available from: http://packageinserts.bms.com/pi/pi-baraclude.pdf [Last accessed on 12 November 2014]
-
(2014)
-
-
-
176
-
-
84861687868
-
HBV DNA suppression during entecavir treatment in previously treated children with chronic hepatitis B
-
Pawlowska M, Halota W, Smukalska E, et al. HBV DNA suppression during entecavir treatment in previously treated children with chronic hepatitis B. Eur J Clin Microbiol Infect Dis 2012;3 1(4):571-4
-
(2012)
Eur J Clin Microbiol Infect Dis
, vol.31
, Issue.4
, pp. 571-574
-
-
Pawlowska, M.1
Halota, W.2
Smukalska, E.3
-
177
-
-
47149108478
-
Entecavir therapy for lamivudine-refractory chronic hepatitis B: Improved virologic, biochemical, and serology outcomes through 96 weeks
-
Sherman M, Yurdaydin C, Simsek H, et al. Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks. Hepa tology 2008;48(1):99-108
-
(2008)
Hepa Tology
, vol.48
, Issue.1
, pp. 99-108
-
-
Sherman, M.1
Yurdaydin, C.2
Simsek, H.3
-
178
-
-
84858603567
-
Progress in newborn hepatitis B vaccination by birth year cohorts-1998-2007 USA
-
Zhao Z, Murphy TV, Jacques-Carroll L. Progress in newborn hepatitis B vaccination by birth year cohorts-1998-2007, USA. Vaccine 2011;30(1):14-20
-
(2011)
Vaccine
, vol.30
, Issue.1
, pp. 14-20
-
-
Zhao, Z.1
Murphy, T.V.2
Jacques-Carroll, L.3
-
179
-
-
84870504651
-
Using data to guide policy: Next steps for preventing perinatal hepatitis B virus transmission in Cambodia
-
Soeung SC,Thiep C,Duncan R,et al. Using data to guide policy: next steps for preventing perinatal hepatitis B virus transmission in Cambodia. Vaccine 2012, 31, 1, 149-53.
-
(2012)
Vaccine
, vol.31
, Issue.1
, pp. 149-153
-
-
Soeung, S.C.1
Thiep, C.2
Duncan, R.3
-
180
-
-
84921644672
-
Hepatitis B virus in the Lao People's Democratic Republic: A cross sectional serosurvey in different cohorts
-
Black AP, Nouanthong P, Nanthavong N, et al. Hepatitis B virus in the Lao People's Democratic Republic: a cross sectional serosurvey in different cohorts. BMC Infect Dis 2014;14:457
-
(2014)
BMC Infect Dis
, vol.14
, pp. 457
-
-
Black, A.P.1
Nouanthong, P.2
Nanthavong, N.3
-
181
-
-
84861601598
-
Low immune response to hepatitis B vaccine among children in Dakar, Senegal
-
Rey-Cuille MA, Seck A, Njouom R, et al. Low immune response to hepatitis B vaccine among children in Dakar, Senegal. PLoS One 2012;7(5):e38153
-
(2012)
PLoS One
, vol.7
, Issue.5
, pp. e38153
-
-
Rey-Cuille, M.A.1
Seck, A.2
Njouom, R.3
-
183
-
-
80053465684
-
Treatment of chronic hepatitis B virus infection in resource-constrained settings: Expert panel consensus
-
Wiersma ST, McMahon B, Pawlotsky JM, et al. Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus. Liver Int 2011; 31(6):755-61
-
(2011)
Liver Int
, vol.31
, Issue.6
, pp. 755-761
-
-
Wiersma, S.T.1
McMahon, B.2
Pawlotsky, J.M.3
-
184
-
-
84874630976
-
Treatment of chronic Hepatitis B in resource-constrained countries: An economic solution is required
-
Thomas H. Treatment of chronic Hepatitis B in resource-constrained countries: an economic solution is required. J Viral Hepat 2013;20(Suppl 1):2
-
(2013)
J Viral Hepat
, vol.20
, pp. 2
-
-
Thomas, H.1
-
185
-
-
79551576896
-
Evaluation of the compliance with the protocol for preventing perinatal hepatitis B infection in Italy
-
Spada E, Tosti ME, Zuccaro O, et al. Evaluation of the compliance with the protocol for preventing perinatal hepatitis B infection in Italy. J Infect 2011;62(2): 165-71
-
(2011)
J Infect
, vol.62
, Issue.2
, pp. 165-171
-
-
Spada, E.1
Tosti, M.E.2
Zuccaro, O.3
-
186
-
-
84924712346
-
-
GAVI alliance. Investing in immunisation through the GAVI Alliance. The evidence base. Available from Last accessed on 28 November
-
GAVI alliance. Investing in immunisation through the GAVI Alliance. The evidence base. Available from: www.gavialliance.org/library/publications/the-evidence-base/[Last accessed on 28 November 2014]
-
(2014)
-
-
-
187
-
-
84924712345
-
-
A study of pegasys (Peginterferon Alfa-2a) versus untreated control in Children With HBeAg Positive Chronic Hepatitis B. Available from
-
A study of pegasys (Peginterferon Alfa-2a) versus untreated control in Children With HBeAg Positive Chronic Hepatitis B. Available from: https://clinicaltrials.gov/ct2/show/NCT01519960
-
-
-
-
188
-
-
0038045171
-
Peginterferon alpha-2a (40 kDa): An advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B
-
Cooksley WG, Piratvisuth T, Lee SD, et al. Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B. J Viral Hepat 2 003;10(4):298-305
-
(2003)
J Viral Hepat
, vol.10
, Issue.4
, pp. 298-305
-
-
Cooksley, W.G.1
Piratvisuth, T.2
Lee, S.D.3
-
189
-
-
33846938792
-
Genotype B and younger patient age associated with better response to low-dose therapy: A trial with pegylated/nonpegylated interferon-alpha- 2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China
-
Zhao H, Kurbanov F, Wan MB, et al. Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha- 2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China. Clin Infect Dis 2007; 44(4):541-8
-
(2007)
Clin Infect Dis
, vol.44
, Issue.4
, pp. 541-548
-
-
Zhao, H.1
Kurbanov, F.2
Wan, M.B.3
-
190
-
-
77949891974
-
Treatment of viral hepatitis B in children
-
Giacchino R, Cappelli B. Treatment of viral hepatitis B in children. Expert Opin Pharmacother 2010;11(6):889-903
-
(2010)
Expert Opin Pharmacother
, vol.11
, Issue.6
, pp. 889-903
-
-
Giacchino, R.1
Cappelli, B.2
|